Literature DB >> 439232

Renal failure owing to oxalate nephrosis after jejunoileal bypass.

S Das, B Joseph, A L Dick.   

Abstract

Oxalate nephrosis resulted in progressive renal failure in 4 patients after jejunoileal bypass for morbid obesity. In general, increased levels of oxalates in the blood and urine of such patients result from enhanced absorption of exogenous oxalates. Urinary calculous formation is determined further by concomitant deficiency of inhibitor substances, whereas oxalate nephrosis probably occurs as a result of oxalate deposition in renal interstitium via the blood stream. Clinical manifestations of oxalate nephrosis include pain, infection, hematuria and renal failure. Routine postoperative renal function studies and early renal biopsy in suspicious cases are urged to establish early diagnosis. Continued deterioration of renal function, despite therapy with oxalate restruction and oxalate binding agents, indicates a reversal of the bypass to preserve unaffected renal substance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 439232     DOI: 10.1016/s0022-5347(17)56845-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

2.  Jejuno-ileal bypass, enteric hyperoxaluria, and oxalate nephrosis: a role for polarised light in the renal biopsy.

Authors:  K Hicks; G B Evans; M E Rogerson; P Bass
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

Review 3.  Surgical management of morbid obesity.

Authors:  S N Joffe
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

4.  Oxalate nephropathy due to gastrointestinal disorders.

Authors:  H J Canos; G A Hogg; J R Jeffery
Journal:  Can Med Assoc J       Date:  1981-03-15       Impact factor: 8.262

Review 5.  Benchmarking best practices in weight loss surgery.

Authors:  Robert B Lim; George L Blackburn; Daniel B Jones
Journal:  Curr Probl Surg       Date:  2010-02       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.